Search for: "Acorda Therapeutics Inc."
Results 21 - 40
of 49
Sorted by Relevance
|
Sort by Date
18 May 2016, 6:27 am
Acorda Therapeutics, Inc., --- F.3d ----, 2016 WL 2848911, No. 14–4353–cv (2d Cir. [read post]
25 Mar 2022, 2:25 pm
Cir. 2015) (same); Acorda Therapeutics, Inc. v. [read post]
16 Jan 2015, 9:39 am
" Acorda Therapeutics Inc. et al v. [read post]
3 Nov 2014, 4:58 am
Acorda Therapeutics, Inc., 2014 WL 5462547, No. 11 Civ. 8803 (S.D.N.Y. [read post]
8 Oct 2019, 9:44 am
Petitions Denied: A number of petitions that were pending last week have now been denied by the court: Acorda Therapeutics, Inc. v. [read post]
14 Jun 2015, 7:30 pm
Inc. [read post]
5 Sep 2015, 11:58 am
”Bass has filed nine petitions challenging patents since Aug. 24, the day the Patent Trial and Appeal Board declined to review two Acorda Therapeutics Inc. cases. [read post]
28 Sep 2016, 5:03 pm
Acorda Therapeutics, Inc. [read post]
28 Sep 2016, 5:03 pm
Acorda Therapeutics, Inc. [read post]
16 Dec 2016, 12:55 pm
Acorda Therapeutics, Inc., 823 F.3d 51 (2d Cir. 2016), recently adopted that very standard, so there was no need to grant rehearing on this issue.SPD argued that Apotexcouldn’t be reconciled with the opinion here, but the panel found that any “tension” was “only a tension of emphasis, not content. [read post]
3 Sep 2015, 3:06 pm
EndoPharmaceuticals Inc., 438 F.3d 1123, 1134 (Fed. [read post]
2 May 2016, 6:17 am
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
15 Feb 2017, 1:44 pm
” Id.Our decision in Acorda Therapeutics Inc. v. [read post]
22 Jul 2021, 12:40 pm
See Acorda Therapeutics, Inc. v. [read post]
4 Jun 2015, 3:24 pm
“Use of the inter partes review process as a tool to manipulate markets is not what Congress intended,” Acorda Therapeutics Inc. said in a filing asking the agency to reject Bass’s petition to cancel a patent on the multiple sclerosis drug Ampyra.link: http://www.bloomberg.com/news/articles/2015-06-04/then-came-the-hedge-funds-patent-death-squad-causes-a-ruckus [read post]
12 Oct 2015, 12:22 am
In August 2015, Bass failed in his challenge to two patents by Acorda Therapeutics Inc for Ampyra, a drug used to treat multiple sclerosis [noted by theAmeriKat here, while many readers were on holiday]. [read post]
19 Dec 2016, 9:20 am
Acorda Therapeutics, Inc., 823 F.3d 51 (2d Cir. 2016). [read post]
19 Dec 2016, 9:20 am
Acorda Therapeutics, Inc., 823 F.3d 51 (2d Cir. 2016). [read post]
19 Jun 2019, 6:18 am
Acorda Therapeutics, Inc. v. [read post]
3 Nov 2014, 9:48 am
Acorda Therapeutics, Inc., No. 11 Civ. 8803(AT) (S.D.N.Y., Oct. 23, 2014) (citing cases). [read post]
